Cycloleucine

Cycloleucine

SCHEMBL3164459

NC1(C(=O)O)CCC1.NC1(C(=O)O)CCCC1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 1/20 0.48
GRM4 Q14833 8/20 0.44
CYP2C19 P33261 4/20 0.44
CYP1A2 P05177 4/20 0.44
ALOX15 P16050 3/20 0.44
ALDH1A1 P00352 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
GRM8 O00222 2/20 0.44
GRM6 O15303 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
KDM4E B2RXH2 1/20 0.44
GRM2 Q14416 3/20 0.43
GRM3 Q14832 3/20 0.43
LMNA P02545 1/20 0.43
GRM5 P41594 1/20 0.43
MTOR P42345 1/20 0.43
GRM1 Q13255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1-Aminocyclobutane Carboxylic Acid SCHEMBL61734 0.97
Cycloleucine SCHEMBL8495 0.97
Cycloleucine SCHEMBL21462057 0.97 NSD2 (0.50) NSD2GRM4CYP2C19CYP1A2ALOX15
SCHEMBL62221 0.94 NSD2 (0.48) NSD2GRM4CYP2C19CYP1A2ALOX15
Cycloleucine SCHEMBL1704308 0.94 NSD2 (0.48) NSD2GRM4CYP2C19CYP1A2ALOX15
Cycloleucine SCHEMBL1711763 0.94 NSD2 (0.48) NSD2GRM4CYP2C19CYP1A2ALOX15
SCHEMBL744894 0.94 NSD2 (0.48) NSD2GRM4CYP2C19CYP1A2ALOX15
SCHEMBL21423145 0.94 NSD2 (0.48) NSD2GRM4CYP2C19CYP1A2ALOX15
Cycloleucine SCHEMBL3674853 0.94 NSD2 (0.48) NSD2GRM4CYP2C19CYP1A2ALOX15
1-Aminocyclobutane Carboxylic Acid SCHEMBL4949098 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1704165-B1 GLP-1 COMPOUNDS NOVO NORDISK AS (DK) 2010-03-17 EP disclosed
US-6544949-B1 Administering peptide or its derivative for therapy of osteoporosis SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (FR) 2003-04-08 US disclosed